Author Question: While performing an evaluation of a patient in respiratory distress, the therapist notes that the ... (Read 17 times)

storky111

  • Hero Member
  • *****
  • Posts: 561
While performing an evaluation of a patient in respiratory distress, the therapist notes that the patient displays an accentuated decrease in the pulse rate and blood pressure during inspiration. How should the therapist describe this finding?
 
  A. a normal clinical feature
  B. tachycardia
  C. pulsus paradoxus
  D. respiratory alternans

Question 2

During normal spontaneous ventilation, venous return _____________ during inspiration, and _______________ during exhalation.
 
  A. increases; decreases
  B. decreases: increases
  C. remains constant; remains constant
  D. fluctuates; fluctuates



joshraies

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

ANS: C
A. Incorrect response: This finding is not a normal clinical feature.
B. Incorrect response: Classifying this finding as tachycardia cannot be made because the pulse rate is not known.
C. Correct response: Pulsus paradoxus is an exaggeration of the normal variation in the pulse and blood pressure during a spontaneous inspiration. Normally, the pulse and the blood pressure become weaker during inspiration, and strengthen during exhalation. With pulsus paradoxus, the variation that occurs during the ventilatory cycle heightens. This exaggeration occurs because during respiratory distress, patients will inspire more forcefully, and reduce the pleural pressure significantly more than during normal spontaneous ventilation. A fall in systolic pressure of about 10 mm Hg compared with the normal variation is often used at the threshold indicating pulsus paradoxus.
D. Incorrect response: Respiratory alternans is the cyclic variation in spontaneous breathing movements when the patient uses the chest wall muscles only, then alternating with periods of diaphragmatic breathing. Respiratory alternans is a clinical sign of ventilatory muscle fatigue.

Answer to Question 2

ANS: A
A. Correct response: During normal spontaneous ventilation, venous return increases during inspiration, and decreases during exhalation. When the pleural pressure falls during inspiration, venous return to the right ventricle increases. Conversely, with the rise in pleural pressure during exhalation, venous return to the right side of the heart decreases. In the presence of positive-pressure ventilation, pleural pressure increases during the inspiratory phase and venous return decreases. When the influence of positive pressure is removed at the end of inspiration, venous return improves during the expiratory phase.
B. Incorrect response: See explanation A.
C. Incorrect response: See explanation A.
D. Incorrect response: See explanation A.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library